Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PRO9830 antibodies

PRO9830 antibodies

US Patent 7456261 · Granted Nov 25, 2008

Estimated economic value: $237,866,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Methods for treating fibrodysplasia ossificans progressiva2025
Method to use gene expression to determine likelihood of clinical outcome of ren2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Method to use gene expression to determine likelihood of clinical outcome of ren2023
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
Antibodies to matrix metalloproteinase 92023
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for can2023
Gene expression profile algorithm for calculating a recurrence score for a patie2023